Phase III trial of docetaxel (D) and carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)
Giannakakis, Th, Mavroudis, D, Papadouris, S, Kourousis, Ch, Ziras, N, Kakolyris, S, Kalbakis, K, Agelaki, S, Zianni, D, Zianni, V, Lidaki, E, Vakaloudi, N, Papadakis, E, Androulakis, N, Souklakos, J,Volume:
21
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(98)90060-5
Date:
September, 1998
File:
PDF, 224 KB
english, 1998